Author:
Reginster J. Y.,Gillot Vincent,Bruyere Olivier,Henrotin Yves
Publisher
Springer Science and Business Media LLC
Reference50 articles.
1. Points to consider on clinical investigation of medicinal products used in the treatment of osteoarthritis 1998, http://www.eudra.org/humandocs/humans/ref.htm.
2. FDA: Guidance for Industry: Clinical Development Programs for Drugs, Devices, and Biological Products Intended for the Treatment of Osteoarthritis. Washington, DC: Food and Drug Administration; 1999:7.
3. Dougados M, Devogelaer JP, Annefeldt M, et al.: Recommendations for the registration of drugs used in the treatment of osteoarthritis. Ann Rheum Dis 1996, 55:552–557.
4. Hardingham TE: Chondroitin sulfate and joint disease. Osteoarthritis Cartilage 1998, 6(SA):3–5.
5. Hardingham TE, Fosang AJ: Proteoglycans: many forms, many functions. FASEB J 1992, 6:861–870.
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献